“A few dozen cases of Avigan reported improvement in administration symptoms."
“Expanded clinical research and started increasing drug production."
On the other hand, the National Medical Products Administration of China has approved the use of Avigan or Favipiravir or Favilavir, an anti-viral drug, as a treatment for coronavirus. The drug has reportedly shown efficacy with minimal side effects in a clinical trial involving hundreds of patients in China and Japan.
In an interview excerpt video of DOH USEC Eric Domingo, he said Japan's Avigan show encouraging results. Watch the video below. You can watch Dobol B Sa News TV Livestream | March 30, 2020 | Replay
The drug has already shown signs of being effective in relieving symptoms after being administered in dozens of cases, Abe said, adding it has attracted interest from many countries. Japan "will proceed with clinical research in cooperation" with other countries and will start increasing production soon.
AVIGAN, to be approved as a formal coronavirus medicine
Ayon sa news na ito, naglabas ng pahayag ang Prime Minister ng Japan kahapon March 28 na inihahanda na nila sa ngayon ang clinical process na dapat gawin upang formally na maaprobahan ang AVIGAN bilang gamot sa coronavirus.
Nais nilang isagawa ito matapos na makatanggap sila ng maraming report mula rin sa ibang bansa na meron din itong effect upang magamot ang mga pasyente. Ang AVIGAN daw ay effective to avoid propagation, growth or breeding of coronavirus sa loob ng katawan ng pasyente. Meron din itong side effect kung kayat hindi ito ginagamit na formal medicine laban sa influenza.
Nais din nilang isagawa ang mass production nito sa lalong madaling panahon matapos lumabas ang formal approval ng Japan government.
Para naman sa vaccine ng coronavirus, wala pang natutuklasan dito. Subalit ang Japan government ay nakikipag coordinate ngayon sa mga medical university at mga private pharma company upang lalong mapabilis na matuklasan ang mabisang vaccine sa nasabing virus.
Ayon sa news na ito, naglabas ng pahayag ang Prime Minister ng Japan kahapon March 28 na inihahanda na nila sa ngayon ang clinical process na dapat gawin upang formally na maaprobahan ang AVIGAN bilang gamot sa coronavirus.
Nais nilang isagawa ito matapos na makatanggap sila ng maraming report mula rin sa ibang bansa na meron din itong effect upang magamot ang mga pasyente. Ang AVIGAN daw ay effective to avoid propagation, growth or breeding of coronavirus sa loob ng katawan ng pasyente. Meron din itong side effect kung kayat hindi ito ginagamit na formal medicine laban sa influenza.
Nais din nilang isagawa ang mass production nito sa lalong madaling panahon matapos lumabas ang formal approval ng Japan government.
Para naman sa vaccine ng coronavirus, wala pang natutuklasan dito. Subalit ang Japan government ay nakikipag coordinate ngayon sa mga medical university at mga private pharma company upang lalong mapabilis na matuklasan ang mabisang vaccine sa nasabing virus.
First coronavirus vaccine in China due for trial late April
Favilavir (favipiravir) is an antiviral drug made in China by Zhejiang Hisun Pharmaceutical. Based on what we can find, it appears that The National Medical Products Administration of China has approved Favilavir for clinical testing in patients for investigational COVID-19 treatment. Favilavir is currently approved for marketing in the treatment of influenza. It is also currently used in Japan for influenza under the brand-name Avigan.
Ads
How does it work?
Favilavir works as an antiviral that effectively attacks RNA viruses by inhibiting RdRp (RNA-depended RNA polymerase). Approved in China for the treatment of influenza, it is now being clinically tested to see if it also works as a treatment for COVID-19.
Ads
Sponsored Links
China has completed its clinical research on #Favilavir, an antiviral drug for #COVID19. The drug has shortened fever time for #COVID19 patients from 4.2 days to 2.5 days with no adverse reactions, a Ministry of Science and Technology official told the press in China on Tuesday.#coronavirusupdate #China completed clinical research on #Favilavir (antiviral drug)— AC Vasquez (@criskotsu) March 17, 2020
Favilavir has shortened fever time for #COVID19 patients from 4.2 to 2.5 days with no adverse reactions
-Ministry of Science&Technology#CoronavirusVaccine #coronavirus@CGTNOfficial @WHO @AFP
Is Favilavir an antiviral drug?
Yes. Favilavir is an antiviral drug that is approved in China for influenza treatment and is now approved for clinical trials to see if it works for coronavirus treatment.
Is Favilavir approved by the WHO and FDA?
Favilavir is not currently approved by WHO or the U.S. Food and Drug Administration (FDA). It is in the process of getting its approval.
How does Favilavir work?
Favilavir’s drug mechanism of action is as an antiviral. It attacks RNA viruses by inhibiting RdRp (RNA-dependent RNA polymerase).
Is Favilavir the same as Fapilavir?
Favilavir was formerly called Fapilavir but is now called Favilavir. The reason for the name change is not clear. The active ingredient is favipiravir.
When will Favilavir be available to patients?
Currently, Favilavir is available to patients in Japan. It is also available to patients in China who are being treated for influenza and is being used in clinical trials for coronavirus treatment. It is already approved in China and is currently working on WHO approval. Favilavir was also approved in China by the Ministry of Science and Health for coronavirus treatment.
As Wuhan closed its last makeshift hospital on Tuesday, frontline medical workers in these hospitals could finally remove their masks and show their smiling faces.
OTHER NEWS ABOUT FAVILAVIR
OTHER NEWS ABOUT FAVILAVIR
SEE ALSO:
Gobyerno Mamimigay ng P5,000 to P8,000 Dahil sa LockDown at COVID19 sa 18M Pamilyang Mahihirap
More Details Here: THOUGHTSKOTO https://www.jbsolis.com/2020/03/P5K-to-P8K-kada-pamilya.html
Pwede Kang Makaavail ng Pag-IBIG Calamity Loan na P20K Pataas Depende sa Total Contribution
More Details Here: THOUGHTSKOTO https://www.jbsolis.com/2020/03/pwede-kang-makaavail-ng-pag-ibig.html
Gobyerno Mamimigay ng P5,000 to P8,000 Dahil sa LockDown at COVID19 sa 18M Pamilyang Mahihirap
More Details Here: THOUGHTSKOTO https://www.jbsolis.com/2020/03/P5K-to-P8K-kada-pamilya.html
Pwede Kang Makaavail ng Pag-IBIG Calamity Loan na P20K Pataas Depende sa Total Contribution
More Details Here: THOUGHTSKOTO https://www.jbsolis.com/2020/03/pwede-kang-makaavail-ng-pag-ibig.html
US President Trump Mentioned This Drug As Possible Treatment for COVID19
More Details Here: THOUGHTSKOTO https://www.jbsolis.com/2020/03/us-president-trump-announces-drug-covid19-treatment.html
DOLE Magbibigay ng P5000 Unemployment Benefit sa mga Apektado ng COVID19
More Details Here: THOUGHTSKOTO https://www.jbsolis.com/2020/03/dole-COVID19-p5000-assistance.html
List of Disinfectants to Use Against COVID-19 Coronavirus
More Details Here: THOUGHTSKOTO https://www.jbsolis.com/2020/03/covid19-fighting-products-disinfectants.html
This is Favilavir, the First Medicine Developed as COVID19 Treatment
More Details Here: THOUGHTSKOTO https://www.jbsolis.com/2020/03/this-is-favilavir-first-medicine.html
More Details Here: THOUGHTSKOTO https://www.jbsolis.com/2020/03/us-president-trump-announces-drug-covid19-treatment.html
DOLE Magbibigay ng P5000 Unemployment Benefit sa mga Apektado ng COVID19
More Details Here: THOUGHTSKOTO https://www.jbsolis.com/2020/03/dole-COVID19-p5000-assistance.html
List of Disinfectants to Use Against COVID-19 Coronavirus
More Details Here: THOUGHTSKOTO https://www.jbsolis.com/2020/03/covid19-fighting-products-disinfectants.html
This is Favilavir, the First Medicine Developed as COVID19 Treatment
More Details Here: THOUGHTSKOTO https://www.jbsolis.com/2020/03/this-is-favilavir-first-medicine.html
No comments:
Post a Comment